The objective of this study is to assess the safety, tolerability and pharmacokinetics of
intravenous sildenafil (10 mg) administered as a bolus injection to patients with Pulmonary
Arterial Hypertension already receiving and stable on oral Revatio 20 mg TID.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.